Table of contents
May 2003 Vol 3 No 5
In this issue
p311 | doi:10.1038/nrc1090
Research Highlights
Cell cycle: Three-wheel drive
p313 | doi:10.1038/nrc1083
Breast cancer: An elitist sport
p314 | doi:10.1038/nrc1079
In the news
Social responsibility
p314 | doi:10.1038/nrc1085
Therapeutics: Breaking down resistance
p315 | doi:10.1038/nrc1081
In brief
Immunotherapy | Carcinogenesis | Target discovery | Prostate cancer
p315 | doi:10.1038/nrc1086
Tumorigenesis: Changing signals
p316 | doi:10.1038/nrc1078
Immunotherapy: Don't forget the handbrake
p316 | doi:10.1038/nrc1082
Angiogenesis: Culprits uncovered
p317 | doi:10.1038/nrc1080
Therapeutics: It's suffocating in here!
p318 | doi:10.1038/nrc1087
Therapeutics: Killer combination
p318 | doi:10.1038/nrc1088
Drug resistance: Sensitive to change
p319 | doi:10.1038/nrc1084
Trial Watch
Detective work | HRT patches for men
p319 | doi:10.1038/nrc1089
Reviews
Translational strategies for cancer prevention in liver
Thomas W. Kensler, Geng-Sun Qian, Jian-Guo Chen & John D. Groopman
p321 | doi:10.1038/nrc1076
5-Fluorouracil: mechanisms of action and clinical strategies
Daniel B. Longley, D. Paul Harkin & Patrick G. Johnston
p330 | doi:10.1038/nrc1074
Cancer and ageing: rival demons?
Judith Campisi
p339 | doi:10.1038/nrc1073
The circadian clock: pacemaker and tumour suppressor
Loning Fu & Cheng Chi Lee
p350 | doi:10.1038/nrc1072
Tumour-cell invasion and migration: diversity and escape mechanisms
Peter Friedl & Katarina Wolf
p362 | doi:10.1038/nrc1075
Perspectives
Opinion
Cancer revoked: oncogenes as therapeutic targets
Dean W. Felsher
p375 | doi:10.1038/nrc1070
Timeline
Photodynamic therapy for cancer
Dennis E.J.G.J. Dolmans, Dai Fukumura & Rakesh K. Jain
p380 | doi:10.1038/nrc1071
Correspondence
Correspondence: Cancer turnover at old age
Francesco Pompei, Ellen E. Lee & Richard Wilson
| doi:10.1038/nrc1073-c2